Fast Track Designation - Infectious Diseases

Relevant Publications

NRX-101 (D-Cycloserine + Lurasidone) Is Active against Drug-Resistant Urinary Pathogens In Vitro.

Issue Release: 2024

A Drug Discovery Perspective on FDA Expedited Development and Incentive Programs.

Issue Release: 2024

Unfolding rates of 1:1 and 2:1 complex of CX-5461 and c- promoter G-quadruplexes revealed by single-molecule force spectroscopy.

Issue Release: 2024

How Super Is Supertrack? Expediting Care of Fast-track Patients through a Pediatric Emergency Department.

Issue Release: 2024

Claudin 1, 4, 6 and 18 isoform 2 as targets for the treatment of cancer (Review).

Issue Release: 2024

NIRDye 812: A molecular platform tailored for multimodal bioimaging applications of targeted fluorescence- and photoacoustic-guided surgery.

Issue Release: 2023

Clinical development time is shorter for new anticancer drugs approved via accelerated approval in the US or via conditional approval in the EU.

Issue Release: 2023

Cryo-EM structures of human arachidonate 12S-Lipoxygenase (12-LOX) bound to endogenous and exogenous inhibitors.

Issue Release: 2023

GLP-1/GIP analogues: potential impact in the landscape of obesity pharmacotherapy.

Issue Release: 2023

The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer.

Issue Release: 2023

Review of the impact of the FDA\'s Fast Track Designation on biotechnology companies\' share prices.

Issue Release: 2023

Antibody-Drug Conjugates in Gynecologic Cancer.

Issue Release: 2023

Operations Factors Associated with Emergency Department Length of Stay: Analysis of a National Operations Database.

Issue Release: 2023

2022 FDA TIDES (Peptides and Oligonucleotides) Harvest.

Issue Release: 2023

Recent Advances in Localized Immunomodulation Technology: Application of NIR-PIT toward Clinical Control of the Local Immune System.

Issue Release: 2023

Comparative Expedited Regulatory Programs of U.S Food & Drug Administration and Project Orbis Partners.

Issue Release: 2023

GSK\'s gonorrhea vaccine receives fast-track designation to expedite clinical trials.

Issue Release: 2023

RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist.

Issue Release: 2023

Tanezumab for the treatment of osteoarthritis pain.

Issue Release: 2022

Development of mRNA vaccines against respiratory syncytial virus (RSV).

Issue Release: 2022

What are the Challenges in Managing Ebola?

What Are Emerging Infectious Diseases?

How Effective are HIV Antivirals?

How do Infectious Diseases Spread?

What are Antivirals?

What is Gonorrhea?

What is the Impact of Co-Infection on Public Health?

How Can Genomic Information Aid in Vaccine Development?

Where is Yellow Fever Found?

What Are Vector-Borne Diseases and How Are They Affected?

Partnered Content Networks

Relevant Topics